1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Escalon Medical Corp.
  6. News
  7. Summary
    ESMC   US2960743050

ESCALON MEDICAL CORP.

(ESMC)
Delayed OTC Markets  -  01:44 2022-08-02 pm EDT
0.1042 USD   +12.83%
05/13ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
05/13Escalon Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
CI
02/14ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021

02/14/2022 | 04:37pm EDT

Escalon Medical Corp. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported revenue was USD 2.7 million compared to USD 2.9 million a year ago. Net loss was USD 0.053154 million compared to net income of USD 0.098476 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago. For the six months, revenue was USD 5.38 million compared to USD 5.31 million a year ago. Net income was USD 0.264066 million compared to net loss of USD 0.098077 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.02 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to diluted loss per share from continuing operations of USD 0.02 a year ago.


© S&P Capital IQ 2022
All news about ESCALON MEDICAL CORP.
05/13ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
05/13Escalon Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
02/14ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
02/14Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months En..
CI
2021ESCALON MEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
2021Escalon Medical Corp. Reports Earnings Results for the First Quarter Ended September 30..
CI
2021ESCALON MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2021Escalon Medical Corp. Reports Earnings Results for the Full Year Ended June 30, 2021
CI
2021ESCALON MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2021Escalon Medical Corp. Reports Earnings Results for the Third Quarter Ended March 31, 20..
CI
More news
Financials ()
Sales 2021 10,5 M - -
Net income 2021 -0,05 M - -
Net Debt 2021 0,12 M - -
P/E ratio 2021 -15,1x
Yield 2021 -
Capitalization 0,77 M 0,77 M -
EV / Sales 2020 0,23x
EV / Sales 2021 0,16x
Nbr of Employees 41
Free-Float 98,1%
Chart ESCALON MEDICAL CORP.
Duration : Period :
Escalon Medical Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Richard J. DePiano Chairman, President, CEO & General Counsel
Mark G. Wallace COO, Principal Financial & Accounting Officer
Lisa A. Napolitano Independent Director
C. Todd Trusk Independent Director
David James Jacovini Director
Sector and Competitors